Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism.
Key Points Interested in Ionis Pharmaceuticals, Inc.? Here are five stocks we like better. Ionis has a packed 2026-style ...
Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...
The inclusion of health-related quality of life and other patient-reported outcomes in landmark trials for Food and Drug Administration oncology drug approvals: An analysis of cancer drug approvals ...
In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management. Understanding the trade-offs between Delta and Wye connections enables ...
Saudi Vision 2030 has entered Phase 3. Here is what the final stage from 2026 to 2030 will focus on, from growth and jobs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results